Skip to Main content Skip to Navigation

Impact de la surexpression de la protéine nucléophosmine (NPM1) sur la progression des cancers de la prostate

Abstract : The chaperone nucleophosmin (NPM1) is over-expressed in the epithelial compartment of tumoral prostate glands compared to adjacent healthy tissue and may represent one of the key actors that support the neoplastic phenotype of prostate adenocarcinoma cells. Yet, the mechanisms that underlie NPM1 mediated phenotype remain elusive in the prostate. NPM1 is a major multifunctional nucleolar phospho-protein expressed at high level in the granular region of the nucleolus with capacities of shuttling between the nucleolus and the cytoplasm. Initially identified as a major regulator of the ribosome biogenesis, it was more recently demonstrated to bind to histones, to mediate nucleosome formation and to relax chromatin, thereby controlling gene expression. Furthermore, NPM1 was shown to interact with and to inhibit the tumour suppressor proteins P53 and Rb, and consequently to potentiate cell growth and proliferation. All these data emphasize a proto-oncogenic function of NPM1 although some authors described a tumour suppressive function for NPM1 as it acts as a regulator of centrosome duplication and thus may lead to cell apoptosis. All this studies revealed that NPM1 acts as both tumour suppressor and proto-oncogene during tumourigenesis. Although NPM1 detailed functions are starting to be clarified, the role of NPM1 in solid tumours remains to be determined. Here we addressed the question whether NPM1 could potentiate proliferation, migration and invasion capacities of prostate cancer cells and deciphered the mechanism by which it exerts such a control on tumour cell behaviour. Our results show that NPM1 favors cell migration, cell invasion and colony forming of prostate tumor cells. Furthermore, in vivo knock-down of NPM1 leads to a decrease in the growth of LNCaP-derived tumors grafted in nude mice. Such oncogenic-like properties are exerted via a positive regulation of NPM1 on the ERK1/2 kinase phosphorylation in response to EGF stimuli, stimuli which are emphasized in prostate tumours following the setting of an autonomous production of the growth factor. NPM1 could be a target to switch off specifically ERK1/2 pathway activation in order to decrease or inhibit proliferation and to potentiate actual targeted therapies based on EGFR specific inhibition.
Document type :
Complete list of metadatas
Contributor : Abes Star :  Contact
Submitted on : Monday, October 7, 2013 - 11:37:57 AM
Last modification on : Friday, November 27, 2020 - 3:25:10 AM
Long-term archiving on: : Friday, April 7, 2017 - 7:49:05 AM


Version validated by the jury (STAR)


  • HAL Id : tel-00870415, version 1



Gaëlle Loubeau. Impact de la surexpression de la protéine nucléophosmine (NPM1) sur la progression des cancers de la prostate. Sciences agricoles. Université Blaise Pascal - Clermont-Ferrand II, 2012. Français. ⟨NNT : 2012CLF22319⟩. ⟨tel-00870415⟩



Record views


Files downloads